A detailed history of Horst & Graben Wealth Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Horst & Graben Wealth Management LLC holds 12,361 shares of PFE stock, worth $330,285. This represents 0.07% of its overall portfolio holdings.

Number of Shares
12,361
Previous 13,053 5.3%
Holding current value
$330,285
Previous $365,000 2.19%
% of portfolio
0.07%
Previous 0.07%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$27.7 - $31.39 $19,168 - $21,721
-692 Reduced 5.3%
12,361 $357,000
Q2 2024

Jul 23, 2024

SELL
$25.26 - $29.6 $934 - $1,095
-37 Reduced 0.28%
13,053 $365,000
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $1,009 - $1,159
39 Added 0.3%
13,090 $363,000
Q4 2023

Jan 29, 2024

SELL
$26.13 - $33.94 $6,793 - $8,824
-260 Reduced 1.95%
13,051 $375,000
Q3 2023

Oct 24, 2023

BUY
$32.09 - $37.51 $6,193 - $7,239
193 Added 1.47%
13,311 $441,000
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $295,497 - $341,883
8,181 Added 165.71%
13,118 $481,000
Q1 2023

Apr 28, 2023

BUY
$39.39 - $51.28 $1,930 - $2,512
49 Added 1.0%
4,937 $201,000
Q4 2022

Jan 24, 2023

BUY
$41.75 - $54.5 $1,628 - $2,125
39 Added 0.8%
4,888 $0
Q3 2022

Oct 24, 2022

BUY
$43.76 - $53.42 $1,794 - $2,190
41 Added 0.85%
4,849 $212,000
Q2 2022

Aug 01, 2022

BUY
$46.53 - $55.17 $1,768 - $2,096
38 Added 0.8%
4,808 $252,000
Q1 2022

Apr 27, 2022

BUY
$45.75 - $56.69 $1,326 - $1,644
29 Added 0.61%
4,770 $247,000
Q4 2021

Jan 20, 2022

BUY
$41.32 - $61.25 $1,280 - $1,898
31 Added 0.66%
4,741 $280,000
Q3 2021

Nov 02, 2021

BUY
$39.25 - $50.42 $184,867 - $237,478
4,710 New
4,710 $203,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Horst & Graben Wealth Management LLC Portfolio

Follow Horst & Graben Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horst & Graben Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horst & Graben Wealth Management LLC with notifications on news.